PRTA Gamma Exposure (GEX)

Net gamma exposure for Prothena Corporation plc (PRTA) options was positive at the Nov 4, 2026 close, about $57.97K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.

Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Gamma Exposure by Strike

Showing results for PRTA, 2026-11-20(m), calls & puts

       

Gamma Exposure Stats

Showing results for PRTA, 2026-11-20(m), calls & puts



Net Gamma Exposure by Expiration

Showing results for PRTA, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net GEX Call GEX Put GEX Call Wall Put Wall Gamma Flip

PRTA Gamma Exposure FAQ

What is gamma exposure (GEX)?

Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.

Is PRTA gamma exposure positive or negative?

Prothena net gamma exposure was positive on Nov 4, 2026, at $57.97K. It has been positive on 20 of the last 20 trading days.

How has PRTA gamma exposure changed recently?

Prothena net gamma exposure went from $26.35K on Oct 7, 2026 to $57.97K on Nov 4, 2026. See the PRTA gamma exposure history for a longer view.

What is Prothena Corporation plc?

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases.

Give feedback on this chart